ROBERT F KENNEDY JR: America must win the race for medical innovation

Key Points:

• The United States is losing its leadership in clinical research and medical innovation, with China now conducting more early-stage clinical trials and accounting for nearly half of global pharmaceutical licensing deals in 2025.
• Clinical trials are crucial for medical progress, attracting investment, talent, and infrastructure, and their relocation overseas threatens the U.S.'s strategic advantage in medical innovation.
• The Department of Health and Human Services (HHS), under President Trump, is launching coordinated efforts involving FDA, NIH, CMS, ONC, ARPA-H, and the HHS Office of Inspector General to strengthen and expedite clinical research in the U.S.
• Initiatives include streamlining trial phases, leveraging AI and digital tools to enhance trial efficiency, improving patient enrollment, and removing regulatory barriers while maintaining scientific and ethical standards.
• The government emphasizes collaboration with researchers, health systems, and industry stakeholders to modernize processes, accelerate innovation, and restore America's global leadership in clinical research.